Barhemsys

Chemical Nameamisulpride
Dosage FormInjection (intravenous; 5 mg/2 mL, 10 mg/4 mL)
Drug ClassReceptor antagonists
SystemDigestive
CompanyAcacia Pharma, Inc.
Approval Year2020

Indication

  • Indicated in adults for prevention of postoperative nausea and vomiting (PONV), either alone or in combination with an antiemetic of a different class.
  • Indicated in adults for treatment of PONV in patients who have received antiemetic prophylaxis with an agent of a different class or have not received prophylaxis.
Last updated on 12/9/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Brand (chemical) Prescribing Information.2020Acacia Pharma Inc. Indianapolis, IN